Complete a survey about a new
Enzalutamide is a new type of
hormone therapy for men with advanced prostate cancer.
The National Institute for Health and Care
Excellence (NICE) is reviewing enzalutamide to look at the costs,
benefits and risks associated with using it. We would like to
hear your thoughts on this drug.
Your opinions are very useful and will help us
make sure that the views of people affected by prostate cancer are
considered by NICE. We would still like to hear your views even if
you have not heard of enzalutamide before.
Find out more
Back to the top